U.S. Neurology Clinical Trials Market Size & Outlook
U.S. neurology clinical trials market, 2018-2030 (US$M)
Related Markets
U.S. neurology clinical trials market highlights
- The U.S. neurology clinical trials market generated a revenue of USD 2,460.0 million in 2023 and is expected to reach USD 3,589.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, phase ii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Neurology clinical trials market data book summary
| Market revenue in 2023 | USD 2,460.0 million |
| Market revenue in 2030 | USD 3,589.2 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Phase ii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
| Key market players worldwide | Novartis AG ADR, Labcorp Holdings Inc, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, GlaxoSmithKline Consumer Healthcare (GSK CH India), Aurora Innovation Inc Class A, Biogen Inc, IQVIA Holdings Inc, inVentiv Health |
Other key industry trends
- In terms of revenue, U.S. accounted for 44.6% of the global neurology clinical trials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. neurology clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,589.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurology Clinical Trials Market Scope
Neurology Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. neurology clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurology clinical trials market will help companies and investors design strategic landscapes.
Phase ii was the largest segment with a revenue share of 40.6% in 2023. Horizon Databook has segmented the U.S. neurology clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. was the largest market in North American region and held more than 94% of the market share in 2021. This can be attributed to the fact that majority of the clinical trials are being performed in the U.S. As of June 2022, over 32% of global clinical trials were registered in the U.S., according to the CLinicalTrials.gov.
Moreover, the biopharmaceutical industry in the U.S. has been the world leader in development of new medicines. The presence of well-established CROs, pharmaceutical, and biopharmaceutical companies, such as IQVIA; ICON plc; Syneos Health, Inc.; Charles River Laboratory, and Biogen, Inc.
In the U.S., is expected to have a positive impact on the market, as these players are also adopting strategies such as initiation of new trials for neurology research, collaboration for clinical studies, and geographic expansion. The adoption of such strategies is likely to benefit the U.S. market.
Reasons to subscribe to U.S. neurology clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. neurology clinical trials market databook
-
Our clientele includes a mix of neurology clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. neurology clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into U.S. neurology clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. neurology clinical trials market size, by phase, 2018-2030 (US$M)
U.S. Neurology Clinical Trials Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
